NEKTAR THERAPEUTICS Annual Weighted Average Number of Shares Outstanding, Basic from 2016 to 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Nektar Therapeutics quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from 2016 to 2023.
  • Nektar Therapeutics Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 209M shares, a 9.9% increase year-over-year.
  • Nektar Therapeutics annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 190M shares, a 1.53% increase from 2022.
  • Nektar Therapeutics annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 187M shares, a 2.1% increase from 2021.
  • Nektar Therapeutics annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 183M shares, a 2.64% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 190M +2.86M +1.53% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-05
2022 187M +3.84M +2.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-05
2021 183M +4.72M +2.64% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-05
2020 179M +3.59M +2.05% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 175M +5.39M +3.18% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 170M +13.6M +8.75% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-26
2017 156M +16.4M +11.7% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-28
2016 140M Jan 1, 2016 Dec 31, 2016 10-K 2019-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.